- Home
- CCG vs SNTI Comparison
CCG vs SNTI Comparison
Compare CCG & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- SNTI
- Stock Information
- Founded
- CCG 2014
- SNTI 2016
- Country
- CCG China
- SNTI United States
- Employees
- CCG N/A
- SNTI N/A
- Industry
- CCG
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- SNTI Health Care
- Exchange
- CCG Nasdaq
- SNTI Nasdaq
- Market Cap
- CCG 75.1M
- SNTI 85.3M
- IPO Year
- CCG N/A
- SNTI N/A
- Fundamental
- Price
- CCG $0.85
- SNTI $3.26
- Analyst Decision
- CCG
- SNTI Strong Buy
- Analyst Count
- CCG 0
- SNTI 1
- Target Price
- CCG N/A
- SNTI $12.00
- AVG Volume (30 Days)
- CCG 260.6K
- SNTI 226.1K
- Earning Date
- CCG 05-29-2025
- SNTI 05-06-2025
- Dividend Yield
- CCG N/A
- SNTI N/A
- EPS Growth
- CCG N/A
- SNTI N/A
- EPS
- CCG N/A
- SNTI N/A
- Revenue
- CCG $475,831,129.00
- SNTI N/A
- Revenue This Year
- CCG N/A
- SNTI N/A
- Revenue Next Year
- CCG $7.06
- SNTI N/A
- P/E Ratio
- CCG N/A
- SNTI N/A
- Revenue Growth
- CCG 5.20
- SNTI N/A
- 52 Week Low
- CCG $0.56
- SNTI $1.52
- 52 Week High
- CCG $2.39
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- CCG 47.10
- SNTI 44.18
- Support Level
- CCG $0.83
- SNTI $3.10
- Resistance Level
- CCG $0.88
- SNTI $3.47
- Average True Range (ATR)
- CCG 0.06
- SNTI 0.42
- MACD
- CCG 0.00
- SNTI -0.07
- Stochastic Oscillator
- CCG 21.58
- SNTI 16.74
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.